AI OCT for Wet AMD

Book free trial to see how AI can detect Wet AMD and 70+ other pathologies/biomarkers

Book Intro

AI for Wet AMD on OCT detects the earliest pathology’s hallmarks, such as fluids, drusen, outer retinal tubulations and others.
Altris AI, AI for OCT scan analysis, provides:

Standardized and reproducible examination: accurate volumetric and area measurements down to micrometers.
Biomarker and pathology segmentation, color-coding, and quantifying, including changes associated with early or subtle Wet AMD.
Specialized drusen and fluids calculations.
Progression analysis: monitoring the results of the Wet AMD treatment objectively.

Platform overview

Only practical features for eye care specialists and clinical research

GDPR compliant (all data is encrypted), CE-certified, and FDA- cleared (510k).

William C. Fruchtman, Optometry Owner

I was really excited to find Altris AI to bolster my skills identifying certain macular diseases. It's a great program and has guided me in the diagnosis of complex cases.

3 Oct, 2024

Scott Sedlacek Optometry Owner

Altris AI identified and described pathology that I could not. Early detection changes the treatment from doing nothing to something. Also, Altris AI described something that I thought was worse than it was. Saved me from over-referring. Patients love to see the color-coded images which help as an educational tool and get buy-in on the treatment plan which helps compliance.

1 Feb, 2024

Richard Clare Optometry Owner

We are adding a new OCT to one of our practices and may benefit from some extra support with AI to speed up the interpretation of results and assist the busy Optometry team.

Dec 7, 2023

Make informed decisions based on objective insights.
Use AI OCT for nAMD detection, monitoring and treatment.

Add: OCT examinations from different visits to assess the effectiveness of treatment.

Detect: see all the biomarkers of Wet AMD with the help of color-coding.

Identify: explore Wet AMD biomarkers in terms of area and volume.

Track: how Wet AMD biomarkers progress over time quantitatively

How Altris AI works?

And what's the value of using AI for Neovascular AMD

A few facts about Altris AI.It is a web platform created by retina experts for all eye care specialists and clinicians.

Automatically prioritize scans based on the presence and extent of pathology.
Detect over 70 pathologies and signs, including early Wet AMD indicators like layers disruption, fluids, and unusual hypo or hyperreflectivity.
Measure and track pathological changes across multiple examinations.
Create customizable reports to enhance communication and facilitate informed decision-making for both you and your patients.

Formats

DICOM format will help you to extract maximum information. However, the system works with all
data formats, such as jpg, and png

OCT equipment

Altris AI is vendor-neutral. We work with all the OCT equipment producers

OCT reports

We create comprehensible OCT reports for patients and doctors

For clinical research

What you get with Altris AI:

Accelerate ophthalmic drug trial.
Detect over 70 retinal pathologies and biomarkers with unparalleled precision.
Analyze biomarkers on OCT scans before and after the treatment quantitatively.
Track the progression of biomarkers to assess drug efficiency.
Enroll the right patients based on fast biomarker detection.
Reduce costs associated with manual scan review with automated analysis.

For eye care